NCT00397553View on ClinicalTrials.gov

Insulin Glulisine, Diabetes Mellitus Type 1

PHASE3CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2007

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG

Insulin glulisine

Trial Locations (1)

Unknown

Sanofi-Aventis, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY